A Montgomery County Circuit Court judge is considering revising a temporary restraining order that has kept the issuance of medical marijuana business licenses in limbo. But what that change would entail is still unknown. Judge James Anderson on Tuesday heard arguments from attorneys representing the Alabama Medical Cannabis Commission and …
The Daily Hit: September 4, 2024
The Daily Hit is a recap of the top financial news stories for Wednesday, September 4, 2024. On the Site Audit reveals California regulators bungled $100 million cannabis licensing aid program The program was established in 2021 but expires in June 2025, at which point the cities and counties will …
IGC Pharma targets Alzheimer’s market with anti-amyloid drug candidate
IGC Pharma Inc. (NYSE: IGC), which was formerly known as India Globalization Capital, announced Wednesday it plans to advance its drug candidate IGC-AD1 into clinical trials as a potential anti-amyloid treatment for Alzheimer’s disease. The move follows recent FDA approvals of anti-amyloid drugs from Eli Lilly and Eisai/Biogen, signaling growing …
NORML Op-Ed: DEA’s Marijuana Hearing Is a Good Opportunity for Advocates To Make the Case for Rescheduling
Nearly 40 years ago, advocates made the case to the DEA’s own judge that cannabis did not meet the definition of a Schedule I controlled substance. Their case is exponentially stronger now. The post NORML Op-Ed: DEA’s Marijuana Hearing Is a Good Opportunity for Advocates To Make the Case for Rescheduling appeared first on NORML.